Mutations in the COL5A1 coding sequence are not common in patients with spontaneous cervical artery dissections

Stroke

Volumn 30, Issue 9, 1999, Pages 1887-1890

  Grond Ginsbach, Caspar ^a   Weber, Ralf ^a   Haas, Juergen ^a   Orberk, Erdem ^a   Kunz, Stefanie ^a   Busse, Otto ^a   Hausser, Ingrid ^a   Brandt, Tobias ^a   Wildemann, Brigitte ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Connective tissue disorders; Dissection; Genetics; Mutation

Indexed keywords

COLLAGEN FIBER; COMPLEMENTARY DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTERY DISSECTION; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; EHLERS DANLOS SYNDROME; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0032825713     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.9.1887     Document Type: Article

References (23)

1. Guillon B, Levy C, Bousser M-G. Internal carotid artery dissection: an update. J Neural Sei. 199S;153:146-158.
2. Schievink WI, Wijdicks EFM, Michels VV, Vockley J, Godfrey, M. Heritable connective tissue disorders in cervical artery dissections: a prospective study. Neurology. 1998;50:1166-1169.
3. Brandt T, Hausser I, Orberk E, Grau A, Hartschuh W, AntonLamprecht I, Hacke W. Ultrastructural connective tissue abnormalities in patients with spontaneous cervico-cerebral artery dissections. Ann Neural. 1998:44:281-285.
4. Hausser I, Anton-Lamprecht I. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-1V as a means of diagnostics and classification. Hum Genet. 1994;3:394-407.
5. Greenspan DS, Cheng W, Hoffman GG. The pro-alpha 1(V) collagen chain: complete primary structure, distribution of expression, and comparison with the pro-alpha 1(XI) collagen chain. J Biol Chem. 1991;266:24727-24733.
6. Takahara K, Seto Y, Okazawa K, Okamoto N, Noda A, Yaoi Y, Kalo I. Complete primary structure of human collagen alpha 1(V) chain. J Biol Chem. 1991:266:13124-13129.
7. Takahara K, Hoffman GG, Greenspan DS. Complete structural organization of the human alphal(V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995;29:588-597.
8. Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sei. 1990;95:649-657.
9. Olsen BR. New insights into the function of collagens from genetic analysis. Curr Op'm Cell Biol. 1995;7:720-727.
10. Andrikopoulos K, Liu K, Keene DR, laenisch R, Ramirez F. Targeted mutation in the COL5A2 gene reveals a regulatory risk for type V collagen during matrix assembly. Nat Genet. 1995;9:31-36.
11. Michalickova K; Susie M; Willing MC, Wenstrup RJ, Cole WG. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I. Hum A/o/ Genet. 1998;7:249-255.
12. Haas S, Vingron M, Poustka A., Wiemann S. Primer design for large scale sequencing. Nucl Acid Res. 1998:26:3006-3012.
13. Wenstrup RJ, Langland GT, Willing MC, D'Souza VN, Cole WG. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro a (V) chains results in the gravis form of Ehlers-Danlos syndrome (type I). Hum Mol Genet. 1996;5: 1733-1736.
14. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993;5:111-117.
15. Hayashi K. PCR-SSCP: a method for detection of mutations. Genet Anal Tech Appl. 1992;9:73-79.
16. Rost B, Sander C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins. 1994;19: 55-72.
17. Kuivaniemi H, Prockop DJ, Wu Y, Madhatheri SL, Kleinen C, Earley JJ, Jokinen A, Stolle C, Majamaa K, Myllyla VV, Norrgard O, Schievink WI, Mokri B, Fukawa O, ter Berg JWM, De Paepe A, Lozano AM, Leblanc R, Ryynanen M, Baxter BT, Shikata H, Ferell RE, Tromp G. Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology. 1993;43:2652-2658.
18. van den Berg JSP, Limburg M. Pals G, Arwert F, Westerveld A, Hennekam RC, Albrecht KW. Some patients with intracranial aneurysms have a reduced type Ill/type I collagen ratio: a case-control study. Neurology. 1997;49:1546-1551.
19. van den Berg JS, Limburg M, Kappelle LJ, Pals G, Arwert F, Westerveld A. The role of type HI collagen in spontaneous cervical arterial dissections. Ann Neural. 1998;43:494-498.
20. Cappa F, Caridi G, Gimelli G, Ghiggeri GM. A new biallelic DNA polymorphism of the human COL5A1 gene. Hum Genet. 1995;95: 599-600.
21. Thompson JP, Simkevich CP, Holness MA, Kang AH, Raghow R. In vitro methylation of the promoter and enhancer of pro alpha 1(1) collagen gene leads to its transcriptional inactivation. J Biol Chem. 1991 Feb 5:266:2549-2556.
22. Willing MC, Slayton RL, Pitts SH, Deschenes SP. Absence of mutations in the promoter of the COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I. J Med Genet. 1995;32: 697-700.
23. Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Anna Rev Biochem. 1995;64:403-434.